These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 10499831)
1. Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis. Sastry PS Med Hypotheses; 1999 Jul; 53(1):76-7. PubMed ID: 10499831 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis. Chofflon M; Roth S; Juillard C; Paunier AM; Juillard P; Degroote D; Grau GE Eur Cytokine Netw; 1997 Sep; 8(3):253-7. PubMed ID: 9346357 [TBL] [Abstract][Full Text] [Related]
16. The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line. Kim YS; Kim JS; Jung HC; Song IS Mol Cells; 2004 Apr; 17(2):210-6. PubMed ID: 15179032 [TBL] [Abstract][Full Text] [Related]
17. A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma. Brenne AT; Romstad LH; Gimsing P; Juliusson G; Turesson I; Romundstad P; Borset M; Sundan A; Waage A Haematologica; 2004 May; 89(5):552-6. PubMed ID: 15136218 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of experimental colitis by thalidomide. Kenet G; Wardi J; Avni Y; Aeed H; Shirin H; Zaidel L; Hershkoviz R; Bruck R Isr Med Assoc J; 2001 Sep; 3(9):644-8. PubMed ID: 11574978 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts. Grzasko N; Dmoszynska A; Hus M; Soroka-Wojtaszko M Haematologica; 2006 Mar; 91(3):386-9. PubMed ID: 16531263 [TBL] [Abstract][Full Text] [Related]